Clinical trial
A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients…
NCT00047658 · InterMune, Industry · Completed
Key facts
| NCT number | NCT00047658 |
|---|---|
| Title | A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
| Official title | A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Biology, and Clinical Effects of Interferon Gamma-1b Administered Subcutaneously to Patients With IPF Followed by an Open-Label Extension |
| Lead sponsor | InterMune, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Idiopathic Pulmonary Fibrosis |
| Intervention type | Drug |
| Interventions | Interferon-gamma 1b |
| Enrollment | 32 |
| Start date | Nov 1, 2001 |
| Completion | May 1, 2003 |
| First posted | Oct 11, 2002 |
| Last update posted | Nov 6, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: